Supplemental material
Journal of Medical Economics
Volume 22, 2019 - Issue 12
Related Research Data
The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis
Source:
American Medical Association (AMA)
Economic Burden of Psoriasis in the United States
Source:
American Medical Association (AMA)
Approach to comorbidity in psoriasis
Source:
Wiley
Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis
Source:
Taylor & Francis
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States
Source:
Springer Nature
Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis
Source:
Taylor & Francis
Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups
Source:
Cambridge University Press (CUP)
ANALYSIS OF THE PREVALENCE OF MENTAL DISORDERS IN PSORIASIS: THE RELEVANCE OF PSYCHIATRIC ASSESSMENT IN DERMATOLOGY
Source:
Medicinska Naklada d.o.o.
Real-world burden of comorbidities in US patients with psoriasis
Source:
Elsevier BV
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
Source:
Academy of Managed Care Pharmacy
Psoriasis
Source:
Elsevier BV
Exploring the Physiological Link between Psoriasis and Mood Disorders.
Source:
Hindawi Limited
The Humanistic and Economic Burden Associated with Anxiety and Depression among Adults with Comorbid Diabetes and Hypertension
Source:
Hindawi Limited
Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
Source:
Oxford University Press (OUP)
Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis
Source:
Academy of Managed Care Pharmacy
Evaluating the economic burden of psoriasis in the United States.
Source:
Elsevier BV
Linking provided by
